1-4 of 4
Xuzhao Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SG301, a Novel Anti-CD38 Monoclonal Antibody, in Patients with Relapsed/Refractory Multiple Myeloma: A First-in-Human, Multicentre, Phase 1 Trial

Ying Tian, Keshu Zhou, Quande Lin, Wenbin Qian, Wei Yang, Li Bao, Guolin Yuan, Xiaojing Yan, Liangming Ma, Xin Zhou, Lihong Liu, Fangbing Zhu, Xuelan Zuo, Xin Du, Xu Ji, Xuzhao Zhang, Jing Shen, Hai Zhou, Na Li, Wenming Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 4746.
https://doi.org/10.1182/blood-2024-199381
Published: 2024
Journal Articles

Early Responders (Time to Best Response ≤3 months) Predicts Functional High-Risk Multiple Myeloma

Yang Xu, Yili Fan, Luyao Wang, Jiawei Zhang, Boxiao Chen, Luyu Yang, Xuzhao Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 3345.
https://doi.org/10.1182/blood-2024-205449
Published: 2024
Journal Articles

Real-World Data of Maintenance Therapy for Newly Diagnosed Multiple Myeloma: Ixazomib Versus Lenalidomide

Yang Xu, Xuzhao Zhang, Luyao Wang, Yili Fan, Boxiao Chen, Luyu Yang, Jiawei Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 3792.3.
https://doi.org/10.1182/blood-2024-205549
Published: 2024
Journal Articles

CD27-Armored BCMA-CAR T Cell (CBG-002) Therapy for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial

Yang Xu, Xuzhao Zhang, Dijia Xin, Jiawei Zhang, Luyao Wang, Yili Fan, Boxiao Chen, Wen Lei, Xi Qiu, Huawei Jiang, Xibin Xiao, Liansheng Huang, Wenjun Yang, Jiangao Zhu, Wenbin Qian
Journal: Blood
Blood (2023) 142 (Supplement 1): 3468.
https://doi.org/10.1182/blood-2023-174364
Published: 2023